Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

189

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
D10AD51	MEDCLINIDERM-T	G	Tretinoin - 0.05%, Clindamycin (phosphate) - 1%		Gel	890,776 L.L
G04BE08	AMOS	G	Tadalafil - 20mg	20mg	Film, orodispersible	2,175,745 L.L
J01DB04	CEFAZOLIN PANPHARMA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	5,521,849 L.L
J01MA12	EVOXIL HELLAS	G	Levofloxacin - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
L01EF01	PALBRANCE 75	G	Palbociclib - 75mg	75mg	Capsule	168,011,222 L.L
L02BX03	ABLAX 250	G	Abiraterone acetate - 250mg	250mg	Tablet	45,056,853 L.L
M01AC01	PIROXICAM	G	Piroxicam - 10mg	10mg	Capsule	353,239 L.L
N01BB09	ROPIVACAINE B. BRAUN	G	Ropivacaine HCl - 75mg/10ml	7.5mg/ml	Injectable solution	4,831,114 L.L
N03AX12	GABAMOX	G	Gabapentin - 300mg	300mg	Capsule, hard	1,108,670 L.L
N05CH01	MELATONINE ARROW LP	G	Melatonin - 2mg	2mg	Tablet, prolonged release	1,716,087 L.L
P02DA01	TENIADEX	G	Niclosamide - 500mg	500mg	Tablet	70,392 L.L
R06AB02	HISTAMED	G	Dexchlorpheniramine maleate - 1%	1%	Gel	477,384 L.L
V03AE02	SEVELAMER CARBONATE ARROW	G	Sevelamer - 2.4g	2.4g	Powder for suspension	12,969,932 L.L
A02BC02	LUGANOR	G	Pantoprazole - 40mg	40mg	Injectable lyophilised powder for solution	463,050 L.L
A07XA04	RACECADOTRIL BGR	G	Racecadotril - 100mg	100mg	Capsule	575,165 L.L
A11CC03	DERIL	G	Alfacalcidol - 1mcg	1mcg	Capsule, soft	783,460 L.L
B05CX01	DEXTROSE	G	Dextrose, H2O - 20g/100ml	20g/100ml	Injectable solution	807,874 L.L
C09CA06	ANDESART 8	G	Candesartan cilexetil - 8mg	8mg	Tablet	498,566 L.L
G04BE08	AMOS	G	Tadalafil - 10mg	10mg	Film, orodispersible	1,662,781 L.L
J01DB04	CEFAZOLINA	G	Cefazolin (sodium) - 1g	1g	Injectable powder for solution	18,574,396 L.L
J01MA12	LEVOFLOXACIN COOPER	G	Levofloxacin (hemihydrate) - 500mg/100ml	500mg/100ml	Injectable solution	959,504 L.L
J07BB01	GC FLU QUADRIVALENT INFLUENZA VACCINE	G	Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml		Injectable suspension	791,523 L.L
L01EF01	PAPILLIO	G	Palbociclib - 75mg	75mg	Capsule, hard	147,883,080 L.L
L02BX03	ABREMIA	G	Abiraterone acetate - 250mg	250mg	Tablet	77,478,802 L.L
M01AC01	INFLACAM	G	Piroxicam - 20mg/ml	20mg/ml	Injectable solution	193,513 L.L
N01BB52	DILOCAIN 2%	G	Lidocaine HCl - 20mg/1.7ml, Epinephrine (bitartrate) - 0.0125mg/1.7ml		Injectable solution	2,768,316 L.L
N03AX12	GABANET 300	G	Gabapentin - 300mg	300mg	Capsule	1,380,126 L.L
N05CM09	RELAXINE TRENKER	G	Valerian extract - 500mg	500mg	Tablet, coated	1,134,203 L.L
P03AB02	GAMMA BENZENE HEXACHLORIDE	G	Lindane - 1%	1%	Shampoo	195,817 L.L
R06AB52	HISTAMED-F	G	Dexchlorpheniramine - 2mg/5ml, Dexamethasone - 0.25mg/5ml		Syrup	712,876 L.L

...

189